[Edaily Reporter KYUNG GYEYOUNG ] Fila Holdings(081660)published its “Sustainability Report” on the 29th, detailing key sustainability performance metrics and its mid- to long-term strategic direction.
Based on the 2030 Sustainability Roadmap—established in line with the Group’s four core values: △Resilient, △Synergetic, △Empowering, and △Responsible—this report presents implementation results and milestones across all Environmental, Social, and Governance (ESG) areas.
In the environmental sector, the company established targets to reduce direct and indirect greenhouse gas emissions (Scope 1 and 2) by 2030 and expanded the scope of greenhouse gas management in its supply chain (Scope 3). It also increased the share of “FILA Re:Deuce,” its circular economy initiative, to 18%.
In the social sector, the company established a strategic framework for supply chain compliance management. Over the past five years, Misto Korea has carried out corporate social responsibility (CSR) activities totaling 12.8 billion won, while the Misto Group has pursued mutual growth with local communities through initiatives such as brand experience spaces. In the governance sector, the company undertook measures to enhance corporate value, including the cancellation of treasury shares.
A representative from Misto Holdings Corporation stated, “Corporate sustainability is determined not by mere declarations of goals, but by execution and data-driven management capabilities,” adding, “Moving forward, we will continue to use our 2030 Sustainable Management Roadmap as our compass to continuously enhance our response to climate change, supply chain management, and responsible governance, thereby simultaneously increasing long-term corporate value and stakeholder trust.”
A single game has generated cumulative sales of 600 billion won. We’re talking about the mobile adventure RPG “Guardian Tales,” which was simultaneously released in approximately 230 countries worldwi…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
Cha Sang-hoon, CEO of AprilBio Co.,Ltd. (Photo courtesy of AprilBio Co.,Ltd.)
Cha Sang-hoon, CEO of AprilBio Co.,Ltd.(397030), who stepped down from management this year, has seized an opportunity…